Resveratrol-Loaded Pluronic Micelles Ameliorate Scopolamine-Induced Cognitive Dysfunction Targeting...

Area of Science:

• Neuroscience
• Pharmacology
• Biotechnology

Background:

• Resveratrol (RVT) shows potential for Alzheimer's disease (AD) treatment.
• Low bioavailability of RVT limits its therapeutic application in AD.
• Developing effective delivery systems is crucial for RVT's neuroprotective potential.

Purpose of the Study:

• To assess resveratrol-loaded micelles (mRVT) as a neuronal delivery platform.
• To evaluate the efficacy of mRVT in a rat model of scopolamine-induced memory impairment.
• To compare the effects of mRVT and pure RVT on cognitive function and neuronal markers.

Main Methods:

• Resveratrol was encapsulated into Pluronic micelles (approx. 33 nm, 79% efficiency).
• Male Wistar rats received scopolamine to induce dementia, followed by treatment with RVT or mRVT.
• Memory performance was assessed using a T-maze test.
• Neurotransmitter levels, protein expression (CREB, Bcl2/BAX ratio), and acetylcholinesterase activity were measured biochemically.

Main Results:

• Micellar resveratrol (mRVT) demonstrated a superior protective effect on spatial memory compared to pure RVT.
• mRVT (10 mg/kg) enhanced noradrenalin neurotransmission and acetylcholinesterase inhibition in the hippocampus.
• mRVT increased cAMP-response element-binding protein (CREB) expression and the Bcl2/BAX ratio, indicating anti-apoptotic effects.

Conclusions:

• Resveratrol-loaded micelles represent a promising strategy for enhancing RVT delivery across the blood-brain barrier.
• The micellar system improved cognitive function and provided neuroprotection in an experimental dementia model.
• This micellar formulation holds potential for treating neurodegenerative diseases like Alzheimer's.